Announcements Trials
Browse Landscape

Status

Completed 154Unknown 56Terminated 10Withdrawn 5Recruiting 4Active not recruiting 3Enrolling by invitation 2Not yet recruiting 1

Sponsor Class

OTHER 131INDUSTRY 36OTHER_GOV 6NIH 4NETWORK 2FED 1

Study Type

Observational 4

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 3Myeloid 1

Conditions

Neoplasms 30Prostatic Neoplasms 22Neoplasm Metastasis 20Breast Neoplasms 17Lung Neoplasms 16Colorectal Neoplasms 15Leukemia, Myeloid, Acute 14Pancreatic Neoplasms 13Ovarian Neoplasms 12Urinary Bladder Neoplasms 11Lymphoma 11Hematologic Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Stomach Neoplasms 9Myelodysplastic Syndromes 9Squamous Cell Carcinoma of Head and Neck 8Sarcoma, Kaposi 8Pheochromocytoma 8Multiple Myeloma 8Melanoma 8Lymphoma, Non-Hodgkin 8Leukemia, Lymphocytic, Chronic, B-Cell 8Endometrial Neoplasms 8Carcinoma, Renal Cell 8Burkitt Lymphoma 8Neuroendocrine Tumors 7Mouth Neoplasms 7Kidney Neoplasms 7Glioma 7Thyroid Neoplasms 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × NIH × Leukemia × Clear all
NCT00923507 2026-06-05

Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)

National Institutes of Health Clinical Center (CC)

Recruiting
1,000 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Waldenstrom Macroglobulinemia, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone

NCT01905826 2026-06-05

Natural History Study of GATA2 Deficiency and Related Disorders

National Institutes of Health Clinical Center (CC)

Recruiting
600 enrolled
MyeloidOther hematologic neoplasm

GATA2 Deficiency, Herpes Simplex, Leukemia, Myelodysplastic Syndromes

NCT06856226 2026-05-27

Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

National Institutes of Health Clinical Center (CC)

Recruiting
88 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Hematologic Neoplasms

NCT05237986 2026-05-22

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

National Institutes of Health Clinical Center (CC)

Recruiting
60 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡